The American opioid crisis may be sidelined by COVID-19, but its death toll is higher than ever.  

A digital exhibition examining the intersection of immigration and public health over 130 years has uplifting moments—like home visits immigrants by New York nurses to curb infant mortality and the spread of disease.  

Birth workers of color believe that growing their ranks could help improve outcomes for Black mothers and babies—but it’s also an access issue.  

New research delivers troubling signs that drug-resistant mutations in a malaria parasite may be gaining traction in Rwanda, 

While the CDC and FDA review data today on reports that 6 women experienced very rare but serious blood clots in the brain after receiving the Johnson & Johnson jab, public health experts offered advice–and reassurance that the risk is low–-to the ~7million who already…

In central and South America, progress against tuberculosis is reversing for reasons not fully understood–-but it’s clear the scourge is increasingly concentrated in the region’s prisons.  Since 2000, TB has swelled in the population by 206%.

One possibility: US regulators could follow the lead of Europe, which limited the AstraZeneca vaccine to certain age groups; or it may add cautionary clauses,

COVID-19 has affected the delivery of routine health care and eroded social safety nets around the world—and that has been especially true for vulnerable communities in Eastern Europe, Central Asia, and the Balkans.

The CDC and FDA recommended a temporary pause on the use of Johnson & Johnson’s COVID-19 vaccine in the US out of “an abundance of caution” over 6 cases of a rare but severe type of blood clot among recipients, 

Islamic scholars have urged Muslims not to delay COVID-19 vaccines on account of Ramadan–-but the holiday could still drive up hesitation.